Latest Strategic Funding News

Argosy Minerals has made significant strides in developing its Rincon Lithium Project in Argentina, securing a 40MW energy infrastructure agreement and completing a $2 million placement to fund ongoing feasibility and engineering works.

GreenHy2 Limited has strengthened its cash position to $1.58 million while progressing its flagship Telstra hydrogen storage project and expanding its battery technology portfolio.

Hot Chili Limited confirms a significant copper-gold mineralisation footprint at its La Verde discovery in Chile, completing phase-one drilling and advancing strategic funding discussions for its key projects.

Bastion Mining has taken control of over 90% of Xanadu Mines shares through a takeover bid, moving swiftly to compulsory acquisition and setting the stage for the Kharmagtai project’s next phase.

Paradigm Biopharmaceuticals has advanced its global Phase 3 trial for knee osteoarthritis pain with active patient recruitment in Australia and the US, backed by a $41.2 million convertible note facility. The company also expanded its osteoarthritis portfolio through the acquisition of Proteobioactives and the Pentacoxib™ oral therapy.

Arafura Rare Earths pushes forward with equity funding for its Nolans Project, targeting a €100 million investment from Germany’s Raw Materials Fund amid rising geopolitical tensions reshaping the rare earths landscape.

Ark Mines has secured $1.5 million to advance its Sandy Mitchell Rare Earths project, initiating a key drilling campaign and metallurgical testing aimed at significantly upgrading its resource base.

Ionic Rare Earths’ Brazilian joint venture, Viridion, has advanced to the next phase of securing a substantial US$900 million funding package from Brazilian government agencies to develop rare earth refining and recycling facilities.

Viridis Mining and Minerals has locked in a strategic US$30 million equity funding partnership with leading Brazilian asset managers to accelerate its Colossus Rare Earth Project towards production.

Advanced Health Intelligence Ltd (AHI) reports robust commercial progress and strategic funding moves in Q1 2025 despite ongoing ASX trading suspension and recent NASDAQ delisting. Key partnerships and technology validations position the company for a strong global scale-up.

BlinkLab is advancing its FDA 510(k) clinical trials for autism and ADHD diagnostics, completing its U.S. autism pilot phase and expanding European ADHD recruitment. A recent $7.66 million capital raise supports these efforts as the company targets regulatory approvals in 2026.

Nova Minerals' board recently toured the Estelle Gold and Critical Minerals Project in Alaska, receiving robust support from federal, state, and tribal leaders as the company moves closer to production.